Show summary Hide summary
As state legislatures close their 2026 sessions, a new survey shows the landscape of abortion access is shifting — not because more people are crossing state lines, but because an increasing number are getting medication abortion through remote prescriptions. That change has lawmakers, courts and health providers focused on restricting or defending the delivery of pills sent from providers outside states with bans.
Why medication abortion is the central battleground
A Guttmacher Institute survey released Tuesday found that in 2025, for the first time, more women in the 13 states that ban abortion at all stages of pregnancy obtained care via mailed medication prescribed through telehealth than traveled to other states for in-clinic procedures. That shift helps explain why recent legislative and legal fights concentrate on blocking pills rather than interstate travel.
New York Times hit with lawsuit from US rights agency: claims white staffer was denied promotion
Horoscopes April 27: what every zodiac sign should expect today
The typical regimen uses two drugs — mifepristone followed by misoprostol — authorized for early pregnancy. Many telehealth prescriptions originate in states that enacted laws after the fall of Roe v. Wade designed to protect clinicians who send pills across state lines.
What lawmakers are doing now
Several Republican-led legislatures this year advanced bills aimed at curbing mailed medication or penalizing those who distribute it. In some states, measures would make advertising, distributing or selling abortion pills a felony; in others, proposals would prohibit providers from mailing the drugs into states with bans.
At least three statehouses have already passed statutes that explicitly restrict mailing abortion pills or reclassify mifepristone under stricter controls. Other proposals have cleared one chamber in multiple states but still face negotiation or potential vetoes by governors.
- Legislative restrictions: Bills range from criminalizing distribution to banning mail delivery of medication abortion.
- Partial advances: Several measures have passed a single chamber this year but are not yet law.
- Executive discretion: Governors in some states retain veto power that could block enacted restrictions.
Courts are a second front
Legal challenges are targeting federal rules that permit prescribing mifepristone via telehealth. If courts require in-person dispensing or curb the FDA’s approval pathway, the flow of pills into states with bans could be significantly reduced.
State attorneys general have filed suits in multiple jurisdictions seeking to narrow telehealth prescribing and to limit distribution across state lines. At the same time, some states have brought civil or criminal actions against entities they allege are supplying pills into jurisdictions with bans.
The FDA’s recent approval of a generic version of mifepristone adds another element to these cases, but courts have not settled the broader questions about cross‑state prescribing and mail delivery.
An uneven legislative map and one new ban
Most states that were inclined toward broad abortion bans enacted them in the years after Roe was overturned; only one state this year moved from a legal gray area to a formal gestational limit.
Wyoming enacted a ban restricting abortion to roughly six weeks of pregnancy earlier this year, joining several other states with similar limits. However, the law’s future is uncertain: Wyoming has a recent record of litigation over abortion restrictions, and legal challenges could delay or block enforcement.
Criminalizing patients has not taken hold
Despite repeated proposals, no state this year has enacted statutes that permit criminal prosecutions of people who obtain abortions. Bills aimed at treating abortion as a homicide or otherwise allowing charges against pregnant people have repeatedly floundered in committee or died before floor votes.
Advocacy groups tracking these measures report fewer introductions in 2026 compared with the prior year, even as some activists continue to push for harsher penalties. Legal scholars warn that isolated prosecutions tied to pregnancy-related conduct still occur in individual cases under existing statutes.
Voters will decide in November
Ballot questions this fall will keep reproductive policy in the public eye. Several states will ask voters to affirm or revise constitutional language related to abortion and reproductive decision-making. Some measures would enshrine protections similar to current law; others would revisit decisions state legislatures or courts have already made.
- State ballot measures may confirm or alter protections for reproductive care.
- Timing: voter decisions in November could change the legal backdrop for both lawmakers and courts.
- Practical impact: ballot outcomes may affect access to clinics, the legal risk for providers, and the availability of telehealth options.
What this means for patients and providers is immediate: if mailed medication remains available, medication abortion will continue to be a primary route to care in states with bans. If courts or legislatures succeed in restricting telehealth prescriptions or mail delivery, people living in those states may face longer travel, higher costs, and narrower options for early pregnancy care.
Associated Press reporter Amelia Thomson DeVeaux contributed reporting to the research underlying this overview.
